Carbonic anhydrase (CA) may modulate regional blood flow by mediating chang
es in extra- and intracellular pH. We hypothesized that CA inhibition with
acetazolamide would inhibit the kinetics and magnitude of hypoxic pulmonary
vasoconstriction (HPV). Isolated rabbit lungs were ventilated and perfused
in situ at constant flow, with buffer containing red blood cells. Preparat
ions were sequentially challenged with hypoxic (FIO2 0.05) and/or hypercapn
ic (FICO2 0.10) gas mixtures for 5 or 10 min. In the experimental groups, a
cetazolamide (33 mu M) was added to the perfusate after establishing baseli
ne responses, and gas challenges were repeated; control groups were studied
without acetazolamide. Acetazolamide reduced the increase in pulmonary art
ery pressure (Delta PAP) and the rate of pressure rise by approximately 30-
50% during hypoxia and combined hypoxia/hypercapnia. The reduction in Delta
PAP occurred for both 5 and 10 min challenges. Acetazolamide did not affec
t expired nitric oxide concentrations. We conclude that acetazolamide reduc
es both the magnitude and kinetics of HPV by a mechanism that does not invo
lve nitric oxide. (C) 2000 Elsevier Science B.V. All rights reserved.